DK0653210T3 - Intravenøst administrerbar vandig opløsning af sulfametrol og trimethoprim - Google Patents

Intravenøst administrerbar vandig opløsning af sulfametrol og trimethoprim

Info

Publication number
DK0653210T3
DK0653210T3 DK94113875.2T DK94113875T DK0653210T3 DK 0653210 T3 DK0653210 T3 DK 0653210T3 DK 94113875 T DK94113875 T DK 94113875T DK 0653210 T3 DK0653210 T3 DK 0653210T3
Authority
DK
Denmark
Prior art keywords
trimethoprim
aqueous solution
sulfametrol
intravenously
intravenously administerable
Prior art date
Application number
DK94113875.2T
Other languages
English (en)
Inventor
Karl Dr Groke
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Application granted granted Critical
Publication of DK0653210T3 publication Critical patent/DK0653210T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94113875.2T 1993-09-14 1994-09-05 Intravenøst administrerbar vandig opløsning af sulfametrol og trimethoprim DK0653210T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4331147A DE4331147A1 (de) 1993-09-14 1993-09-14 Intravenös verabreichbare, wäßrige Lösung

Publications (1)

Publication Number Publication Date
DK0653210T3 true DK0653210T3 (da) 1997-10-06

Family

ID=6497666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94113875.2T DK0653210T3 (da) 1993-09-14 1994-09-05 Intravenøst administrerbar vandig opløsning af sulfametrol og trimethoprim

Country Status (13)

Country Link
US (1) US5554618A (da)
EP (1) EP0653210B1 (da)
JP (1) JPH07149653A (da)
AT (1) ATE150309T1 (da)
CA (1) CA2132034A1 (da)
DE (2) DE4331147A1 (da)
DK (1) DK0653210T3 (da)
ES (1) ES2103526T3 (da)
FI (1) FI944219A7 (da)
GR (1) GR3023841T3 (da)
HU (1) HUT70053A (da)
IL (1) IL110945A0 (da)
ZA (1) ZA947052B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938798A1 (en) * 2002-02-22 2008-07-02 Schering Corporation Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
CA2662899A1 (en) 2002-02-22 2003-09-04 Schering Corporation Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
UA92423C2 (ru) * 2009-07-24 2010-10-25 Анатолій Альбертович Кузьмін Антибактериальная композиция

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT270869B (de) * 1966-05-09 1969-05-12 Hoffmann La Roche & Co Aktiege Verfahren zur Herstellung von Sulfonamid-Potentiator-Lösungen
GB1469521A (en) 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
US5008255A (en) * 1989-01-12 1991-04-16 Alcon Laboratories, Inc. Method for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefrom

Also Published As

Publication number Publication date
US5554618A (en) 1996-09-10
DE59402136D1 (de) 1997-04-24
EP0653210B1 (de) 1997-03-19
HUT70053A (en) 1995-09-28
EP0653210A1 (de) 1995-05-17
FI944219A0 (fi) 1994-09-13
DE4331147A1 (de) 1995-03-16
ES2103526T3 (es) 1997-09-16
JPH07149653A (ja) 1995-06-13
GR3023841T3 (en) 1997-09-30
FI944219L (fi) 1995-03-15
HU9402627D0 (en) 1994-11-28
FI944219A7 (fi) 1995-03-15
CA2132034A1 (en) 1995-03-15
IL110945A0 (en) 1994-11-28
ZA947052B (en) 1995-04-26
ATE150309T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
FI934240A0 (fi) En katalas, dess produktion och anvaendning
DE69429526D1 (de) Selbsthärtende calciumphosphatzemente und verfahren zu deren herstellung und verwendung
SE9202250D0 (sv) Controlled release morphine preparation
TR199902904T2 (xx) Yeni bile�imler.
PT80674A (en) Process for the preparation of pyrazole analogues of mevalonolactone and derivatives thereof
ATE194995T1 (de) Polymerisationsfähige derivate von polyamiden
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
NO973343D0 (no) Antiinflammatoriske öyedråper
DE69425948D1 (de) Zusammensetzung mit verbesserter Wasserlöslichkeit, enthaltend eine Wasserunlösliche oder an Wasser schwerunlösliche Verbindung
TR200001010T2 (tr) Ürokinaz önleyicileri olan izokinolinler.
DK0653210T3 (da) Intravenøst administrerbar vandig opløsning af sulfametrol og trimethoprim
DK218083A (da) Aminoalkadien-derivater, deres fremstilling og anvendelse
DK0397147T3 (da) Stabile opløsninger af rebeccamycinanalog og fremstilling deraf
AU640647B2 (en) 3-butenamide derivatives
FR2424919A1 (fr) Acide quinoleinecarboxylique substitue et ses derives et leur utilisation comme agents antibacteriens
ES2181213T3 (es) Procedimiento para la preparacion de 1,4,7,10-tetraazaciclododecano.
SE9502001L (sv) Sirap innehållande N-acetylcystein
DE69000621D1 (de) Pentamidinloesungen.
ATE60903T1 (de) Stabile, waessrige vincristinsulfatloesung.
DE69625482D1 (de) Phosphinsäurederivate mit metallopeptidase-inhibitorischer wirkung
NO954410D0 (no) Fremgangsmåte og fremstilling av NG-monoalkyl-L-arginin og beslektede forbindelser
ES2082159T3 (es) Derivados de tiourea hidrosolubles y procedimiento para su preparacion.
DE3167839D1 (en) Method for preparing n-(4-(((2,4-diamino-6-pteridinyl)-methyl)methylamino)benzoyl)glutamic acid
DK0661541T3 (da) Fremgangsmåde til fremstilling af langtidsstabile klare sera
MX9605668A (es) Sal de estilbazolio, su preparacion y uso.